About Biomarkers Market
Biomarkers are molecular or cellular diagnostic tools used for effective measurement and evaluation of biological processes, pathogenic procedures, and pharmacological responses to a therapeutic intervention. They act as medical signs in contrast to the conventional method of relying on medical symptoms that are limited to indications of health or illness perceived by patients/doctors. Moreover, in a broader scope, biomarkers are used for assessing the incidence, the outcome of diseases, effects of treatments, interventions, and environmental exposure to nutrients and chemicals. The rising demand for biomarkers in research facilities and increasing R&D focus of global pharmaceutical and biotechnology organizations on biomarkers are driving the category spend.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Biomarkers Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Biomarkers Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category driver
Category constraints
Procurement best practices
Key questions answered in this report
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Biomarkers are molecular or cellular diagnostic tools used for effective measurement and evaluation of biological processes, pathogenic procedures, and pharmacological responses to a therapeutic intervention. They act as medical signs in contrast to the conventional method of relying on medical symptoms that are limited to indications of health or illness perceived by patients/doctors. Moreover, in a broader scope, biomarkers are used for assessing the incidence, the outcome of diseases, effects of treatments, interventions, and environmental exposure to nutrients and chemicals. The rising demand for biomarkers in research facilities and increasing R&D focus of global pharmaceutical and biotechnology organizations on biomarkers are driving the category spend.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Biomarkers Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Biomarkers Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category driver
- Increasing development of new biomarkers
- For a full, detailed list, view our report
Category constraints
- Ensuring proper storage and transportation
- For a full, detailed list, view our report
Procurement best practices
- Employ latest tools for feature selection in biomarkers
- For a full, detailed list, view our report
Key questions answered in this report
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints to category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
- What are the procurement best practices in this market?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 1: CATEGORY AT A GLANCE- TAKEAWAY 01 - Market Overview
- TAKEAWAY 02 - Demand and Supply Snapshot
- TAKEAWAY 03 - Key Market Dynamics
- TAKEAWAY 04 - Supply Market Highlights
- TAKEAWAY 05 - Pricing Insights
- TAKEAWAY 06 - Procurement Insights
PART 2: SCOPE OF THE REPORT
- Category Definition
- Research Methodology
PART 3: MARKET INSIGHTS
- Category Spend Analysis
- Category Maturity by Regions
- Demand-Supply Shifts
- Regional Demand-Supply Snapshot
- Market Developments
- Regional Impact of Trends
- Key Category Growth Drivers and Corresponding Regional Impacts
- Major Category Growth Constraints and Corresponding Regional Impacts
- Key Current Technological Innovations
- Major Regulatory Frameworks
- Strategic Sustainability Practices
- Porter’s Five Forces
- PESTLE Analysis
PART 4: SUPPLY MARKET INSIGHTS
- Supplier Operational Capability Matrix
- Other Prominent Suppliers by Region: Operational Capability Matrix
- Supplier Functional Capability Matrix
- Other Prominent Suppliers by Region: Functional Capability Matrix
- Key Clients and Partners
- Supplier Cost Breakup
- Supplier Positioning Matrix
PART 5: PRICING INSIGHTS
- Pricing Models Snapshot
- Pricing Models - Pros and Cons
- Indicative Pricing
PART 6: PROCUREMENT INSIGHTS
- Major Category Requirements
- Major Procurement Pain Points
- Category Sourcing Evolution Matrix
- Procurement Best Practices
- Cost-saving Opportunities
- Supplier Selection Criteria
- Category Negotiation Strategies
- SLA Terms
- Supplier Evaluation Criteria
- Category Risk Analysis
PART 7: TOP FIVE SUPPLIERS
- Thermo Fisher Scientific
- General Electric
- Merck KGaA
- Abbott
- PerkinElmer
PART 8: APPENDIX
- Glossary
- Key Notes
- About
Executive Summary
New Report Released: Global Biomarkers Category - Procurement Market Intelligence Report 2018-2022.The author of the report recognizes the following companies as the key suppliers in the Global Biomarkers Category - Procurement Market Intelligence Report: Thermo Fisher Scientific, General Electric, Merck KGaA, Abbott, and PerkinElmer.
Commenting on the report, an analyst from the research team said: “One of the best procurement practices for the buyers is to assess supplier tie-ups and partnerships.”
According to the report, one of the key growth contributors for the global biomarkers market is the effectiveness of biomarkers in the early stage detection of cancer.
Further, the report states that a major procurement challenge experienced by the buyers is the high switching costs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Companies Mentioned
- Thermo Fisher Scientific
- General Electric
- Merck KGaA
- Abbott
- PerkinElmer
Methodology
LOADING...
